NCT04186598 - Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

September 13, 2023

Study Completion Date

September 13, 2023

Conditions

Continuous Positive Airway PressureHigh Altitude Pulmonary Edema

Interventions

DEVICE

CPAP mask system

Intervention group will receive 15cm of H2O of positive end expiratory pressure

DRUG

Nifedipine 30 MG

All participants will receive this intervention

DEVICE

CPAP mask system without PEEP

Placebo group will receive high flow oxygen via altered CPAP mask system without providing any positive end expiratory pressure

Trial Locations (1)

Breckenridge Medical Center, Breckenridge